Hoth Therapeutics (HOTH) News Today $1.55 -0.34 (-17.99%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Hoth Therapeutics: Strong balance sheet includes over $10M cash, no debtJanuary 10, 2025 | markets.businessinsider.comHoth Therapeutics affirms no plans for public, private offering at this timeJanuary 10, 2025 | markets.businessinsider.comHoth Therapeutics responds to market rumors, says no plans for offeringJanuary 10, 2025 | markets.businessinsider.comHoth Therapeutics' (HOTH) "Buy" Rating Reaffirmed at D. Boral CapitalJanuary 9, 2025 | americanbankingnews.comHoth Therapeutics Shares Recover; Company Has No Plans for OfferingJanuary 9, 2025 | marketwatch.comHoth Therapeutics Responds to Market Rumors and Shareholder InquiriesJanuary 8, 2025 | prnewswire.comShares Of This Micro Cap More Than Doubled TodayJanuary 8, 2025 | msn.comHoth Therapeutics reports ‘encouraging’ results from Phase 2a trial of HT-001January 8, 2025 | markets.businessinsider.comD. Boral says Hoth findings highlight HT-001 potential to ‘revolutionize’ careJanuary 8, 2025 | markets.businessinsider.comHoth Therapeutics’ Stock Triples On Promising Cancer Trial Data for Skin Toxicity Therapy: Retail’s ExcitedJanuary 8, 2025 | msn.comHoth Therapeutics Shares Hit 52-Week High on Positive Data for Cancer TreatmentJanuary 7, 2025 | marketwatch.comHoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin ToxicitiesJanuary 7, 2025 | prnewswire.comHoth Therapeutics partners with Dept. of Veterans Affairs on obesity treatmentDecember 27, 2024 | markets.businessinsider.comWhy Hoth Therapeutics Is Rising In Pre-market?December 26, 2024 | markets.businessinsider.comHoth licenses patents to develop anti-obesity treatmentsDecember 26, 2024 | msn.comHoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity TreatmentDecember 26, 2024 | prnewswire.comBitcoin buyer MicroStrategy ends flat after getting Nasdaq 100 nodDecember 17, 2024 | msn.comCanadian Wellness Company Approves $1 Million Bitcoin Treasury InvestmentNovember 27, 2024 | msn.comMicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000November 23, 2024 | msn.comHoth Up on Bitcoin BuyNovember 20, 2024 | baystreet.caHoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve AssetNovember 20, 2024 | prnewswire.comHoth Therapeutics shares hold buy as study shows cancer treatment promiseNovember 7, 2024 | investing.comHoth Therapeutics Up 34% on Favorable Early Data for Preclinical Study of Cancer DrugOctober 30, 2024 | marketwatch.comHoth Therapeutics: Treatment ‘successfully’ stabilized tumor growth in studyOctober 30, 2024 | markets.businessinsider.comHoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment StudyOctober 29, 2024 | prnewswire.comHoth Therapeutics, Inc.October 17, 2024 | cnn.comHoth Shares Rise After Alzheimer's Treatment Gets PatentOctober 15, 2024 | marketwatch.comHoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now UnderwayOctober 15, 2024 | prnewswire.comHoth Therapeutics Reports Encouraging Pre-clinical Data For Its Alzheimer's Drug; Stock UpSeptember 17, 2024 | markets.businessinsider.comHoth Therapeutics Shares Rally on Positive Alzheimer's Pre-clinical Study DataSeptember 17, 2024 | marketwatch.comHoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZSeptember 17, 2024 | prnewswire.comHoth Therapeutics (NASDAQ:HOTH) Stock Quotes, Forecast and News SummarySeptember 6, 2024 | benzinga.comEvolve Canadian Utilities Enhanced Yield Index Fund (UTES.TO)September 5, 2024 | finance.yahoo.comHoth Stock Soars On Announcement Of Positive Data For HT-001 In EGFRI-Associated Skin ToxicitiesSeptember 5, 2024 | markets.businessinsider.comHoth Therapeutics Reports Favorable Results for First-of-Its-Kind HT-001 Treatment of a PatientSeptember 5, 2024 | marketwatch.comHoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a TrialSeptember 5, 2024 | prnewswire.comHoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001September 5, 2024 | prnewswire.comPhanes acquires second FDA orphan designation for bispecific antibodyAugust 20, 2024 | msn.comHoth Therapeutics, Inc. (NASDAQ:HOTH) CEO Acquires 25,000 SharesAugust 20, 2024 | insidertrades.comHoth Therapeutics, Inc. (HOTH) latest stock news & headlines – Yahoo FinanceAugust 18, 2024 | nz.finance.yahoo.comHoth and Aronnax partner for HT-KIT cancer therapy developmentAugust 16, 2024 | finance.yahoo.comHoth, Aronnax Enter Master Services Agreement For HT-KIT Therapeutic - Quick FactsAugust 15, 2024 | markets.businessinsider.comHoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer TherapeuticAugust 15, 2024 | prnewswire.comBuy Rating Affirmed for Hoth Therapeutics on Strategic Partnerships and Promising Alzheimer’s Treatment AdvancesJuly 26, 2024 | markets.businessinsider.comMicro Cap Already Off To The Races At The BellJuly 24, 2024 | theglobeandmail.comWhy Is Hoth Therapeutics (HOTH) Stock Moving Today?July 24, 2024 | investorplace.comHoth Signs Deal With LTS Therapy To Develop & Manufacture HT-ALZ Oral Film Prot; Stock UpJuly 24, 2024 | markets.businessinsider.comHoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's TreatmentJuly 24, 2024 | prnewswire.comHoth Therapeutics’ Expansion and AI Integration Bolster Buy RatingJuly 22, 2024 | markets.businessinsider.comHoth Therapeutics Expands Clinical Trial for Cancer PatientsJuly 16, 2024 | prnewswire.com Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address HOTH Media Mentions By Week HOTH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HOTH News Sentiment▼0.090.79▲Average Medical News Sentiment HOTH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HOTH Articles This Week▼121▲HOTH Articles Average Week Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PDS Biotechnology News OptiNose News Spero Therapeutics News AlloVir News Dyadic International News Elevation Oncology News Tonix Pharmaceuticals News Achilles Therapeutics News Invivyd News Xilio Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HOTH) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hoth Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
